Endo Ketoprofen Patch Fails Two Phase III Studies; Firm Revises 2007 Guidance
This article was originally published in The Pink Sheet Daily
Executive Summary
Endo awaits results from another Phase III efficacy study expected by Aug. 1 before it makes a go/no go decision on the product.